The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Infectious Disease Therapeutics Market Research Report 2025

Global Infectious Disease Therapeutics Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1713706

No of Pages : 86

Ask Your Query

Synopsis

Market Analysis and Insights: Global Infectious Disease Therapeutics Market

Infectious disease therapeutics are targeting on main infectious diseases by using drugs and vaccines to prevent, control and cure them.

The global Infectious Disease Therapeutics market size is projected to reach US$ 59310 million by 2028, from US$ 45730 million in 2021, at a CAGR of 3.7% during 2022-2028.

Major driving factors of the global infectious disease therapeutics market are favorable reimbursement policies for infectious diseases, increasing incidence of infectious diseases, escalating consumption of anti-microbial direct acting drugs, growing geriatric population, rising awareness among population, upsurge in government investment into healthcare to eradicate infectious diseases.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Infectious Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Infectious Disease Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Infectious Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Infectious Disease Therapeutics market.

Global Infectious Disease Therapeutics Scope and Market Size
Infectious Disease Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Infectious Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

  • Drugs
  • Vaccines

Segment by Application

  • HIV/AIDS
  • Influenza
  • Hepatitis
  • Malaria
  • Tuberculosis
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina, Colombia)

By Company

  • Novartis Ag
  • Gilead
  • Glaxosmithkline Plc
  • Janssen Pharmaceutical Inc.
  • F. Hoffmann-La Roche Ltd.
  • Biocryst Pharmaceuticals Inc.
  • Merck & Co. Inc.
  • Boehringer Ingelheim Gmbh
Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Drugs
1.2.3 Vaccines
1.3 Market by Application
1.3.1 Global Infectious Disease Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 HIV/AIDS
1.3.3 Influenza
1.3.4 Hepatitis
1.3.5 Malaria
1.3.6 Tuberculosis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Therapeutics Market Perspective (2017-2028)
2.2 Infectious Disease Therapeutics Growth Trends by Region
2.2.1 Infectious Disease Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Infectious Disease Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Infectious Disease Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Infectious Disease Therapeutics Market Dynamics
2.3.1 Infectious Disease Therapeutics Industry Trends
2.3.2 Infectious Disease Therapeutics Market Drivers
2.3.3 Infectious Disease Therapeutics Market Challenges
2.3.4 Infectious Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Therapeutics Players by Revenue
3.1.1 Global Top Infectious Disease Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Infectious Disease Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Infectious Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Therapeutics Revenue
3.4 Global Infectious Disease Therapeutics Market Concentration Ratio
3.4.1 Global Infectious Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Therapeutics Revenue in 2021
3.5 Infectious Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Infectious Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Infectious Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Therapeutics Breakdown Data by Type
4.1 Global Infectious Disease Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Infectious Disease Therapeutics Forecasted Market Size by Type (2023-2028)
5 Infectious Disease Therapeutics Breakdown Data by Application
5.1 Global Infectious Disease Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Infectious Disease Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Infectious Disease Therapeutics Market Size (2017-2028)
6.2 North America Infectious Disease Therapeutics Market Size by Country (2017-2022)
6.3 North America Infectious Disease Therapeutics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Infectious Disease Therapeutics Market Size (2017-2028)
7.2 Europe Infectious Disease Therapeutics Market Size by Country (2017-2022)
7.3 Europe Infectious Disease Therapeutics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2017-2022)
8.3 Asia-Pacific Infectious Disease Therapeutics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Infectious Disease Therapeutics Market Size (2017-2028)
9.2 Latin America Infectious Disease Therapeutics Market Size by Country (2017-2022)
9.3 Latin America Infectious Disease Therapeutics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2017-2022)
10.3 Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Infectious Disease Therapeutics Introduction
11.1.4 Novartis AG Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 Gilead
11.2.1 Gilead Company Detail
11.2.2 Gilead Business Overview
11.2.3 Gilead Infectious Disease Therapeutics Introduction
11.2.4 Gilead Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.2.5 Gilead Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Detail
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Infectious Disease Therapeutics Introduction
11.3.4 GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Janssen Pharmaceutical Inc.
11.4.1 Janssen Pharmaceutical Inc. Company Detail
11.4.2 Janssen Pharmaceutical Inc. Business Overview
11.4.3 Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Introduction
11.4.4 Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.4.5 Janssen Pharmaceutical Inc. Recent Development
11.5 F. Hoffmann-La Roche Ltd.
11.5.1 F. Hoffmann-La Roche Ltd. Company Detail
11.5.2 F. Hoffmann-La Roche Ltd. Business Overview
11.5.3 F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.5.5 F. Hoffmann-La Roche Ltd. Recent Development
11.6 BioCryst Pharmaceuticals Inc.
11.6.1 BioCryst Pharmaceuticals Inc. Company Detail
11.6.2 BioCryst Pharmaceuticals Inc. Business Overview
11.6.3 BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Introduction
11.6.4 BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.6.5 BioCryst Pharmaceuticals Inc. Recent Development
11.7 Merck & Co. Inc.
11.7.1 Merck & Co. Inc. Company Detail
11.7.2 Merck & Co. Inc. Business Overview
11.7.3 Merck & Co. Inc. Infectious Disease Therapeutics Introduction
11.7.4 Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.7.5 Merck & Co. Inc. Recent Development
11.8 Boehringer Ingelheim GmbH
11.8.1 Boehringer Ingelheim GmbH Company Detail
11.8.2 Boehringer Ingelheim GmbH Business Overview
11.8.3 Boehringer Ingelheim GmbH Infectious Disease Therapeutics Introduction
11.8.4 Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2017-2022)
11.8.5 Boehringer Ingelheim GmbH Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Infectious Disease Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Drugs
Table 3. Key Players of Vaccines
Table 4. Global Infectious Disease Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Infectious Disease Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Infectious Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Infectious Disease Therapeutics Market Share by Region (2017-2022)
Table 8. Global Infectious Disease Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Infectious Disease Therapeutics Market Share by Region (2023-2028)
Table 10. Infectious Disease Therapeutics Market Trends
Table 11. Infectious Disease Therapeutics Market Drivers
Table 12. Infectious Disease Therapeutics Market Challenges
Table 13. Infectious Disease Therapeutics Market Restraints
Table 14. Global Infectious Disease Therapeutics Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Infectious Disease Therapeutics Market Share by Players (2017-2022)
Table 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2021)
Table 17. Ranking of Global Top Infectious Disease Therapeutics Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Infectious Disease Therapeutics Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Therapeutics Product Solution and Service
Table 21. Date of Enter into Infectious Disease Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Therapeutics Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Infectious Disease Therapeutics Revenue Market Share by Type (2017-2022)
Table 25. Global Infectious Disease Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Infectious Disease Therapeutics Revenue Market Share by Type (2023-2028)
Table 27. Global Infectious Disease Therapeutics Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Infectious Disease Therapeutics Revenue Market Share by Application (2017-2022)
Table 29. Global Infectious Disease Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Infectious Disease Therapeutics Revenue Market Share by Application (2023-2028)
Table 31. North America Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Infectious Disease Therapeutics Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Infectious Disease Therapeutics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Novartis AG Company Detail
Table 42. Novartis AG Business Overview
Table 43. Novartis AG Infectious Disease Therapeutics Product
Table 44. Novartis AG Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 45. Novartis AG Recent Development
Table 46. Gilead Company Detail
Table 47. Gilead Business Overview
Table 48. Gilead Infectious Disease Therapeutics Product
Table 49. Gilead Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 50. Gilead Recent Development
Table 51. GlaxoSmithKline plc Company Detail
Table 52. GlaxoSmithKline plc Business Overview
Table 53. GlaxoSmithKline plc Infectious Disease Therapeutics Product
Table 54. GlaxoSmithKline plc Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 55. GlaxoSmithKline plc Recent Development
Table 56. Janssen Pharmaceutical Inc. Company Detail
Table 57. Janssen Pharmaceutical Inc. Business Overview
Table 58. Janssen Pharmaceutical Inc. Infectious Disease Therapeutics Product
Table 59. Janssen Pharmaceutical Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 60. Janssen Pharmaceutical Inc. Recent Development
Table 61. F. Hoffmann-La Roche Ltd. Company Detail
Table 62. F. Hoffmann-La Roche Ltd. Business Overview
Table 63. F. Hoffmann-La Roche Ltd. Infectious Disease Therapeutics Product
Table 64. F. Hoffmann-La Roche Ltd. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd. Recent Development
Table 66. BioCryst Pharmaceuticals Inc. Company Detail
Table 67. BioCryst Pharmaceuticals Inc. Business Overview
Table 68. BioCryst Pharmaceuticals Inc. Infectious Disease Therapeutics Product
Table 69. BioCryst Pharmaceuticals Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 70. BioCryst Pharmaceuticals Inc. Recent Development
Table 71. Merck & Co. Inc. Company Detail
Table 72. Merck & Co. Inc. Business Overview
Table 73. Merck & Co. Inc. Infectious Disease Therapeutics Product
Table 74. Merck & Co. Inc. Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 75. Merck & Co. Inc. Recent Development
Table 76. Boehringer Ingelheim GmbH Company Detail
Table 77. Boehringer Ingelheim GmbH Business Overview
Table 78. Boehringer Ingelheim GmbH Infectious Disease Therapeutics Product
Table 79. Boehringer Ingelheim GmbH Revenue in Infectious Disease Therapeutics Business (2017-2022) & (US$ Million)
Table 80. Boehringer Ingelheim GmbH Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Therapeutics Market Share by Type: 2021 VS 2028
Figure 2. Drugs Features
Figure 3. Vaccines Features
Figure 4. Global Infectious Disease Therapeutics Market Share by Application in 2021 & 2028
Figure 5. HIV/AIDS Case Studies
Figure 6. Influenza Case Studies
Figure 7. Hepatitis Case Studies
Figure 8. Malaria Case Studies
Figure 9. Tuberculosis Case Studies
Figure 10. Others Case Studies
Figure 11. Infectious Disease Therapeutics Report Years Considered
Figure 12. Global Infectious Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Infectious Disease Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Infectious Disease Therapeutics Market Share by Region: 2021 VS 2028
Figure 15. Global Infectious Disease Therapeutics Market Share by Players in 2021
Figure 16. Global Top Infectious Disease Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Therapeutics as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Infectious Disease Therapeutics Revenue in 2021
Figure 18. North America Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Infectious Disease Therapeutics Market Share by Country (2017-2028)
Figure 20. United States Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Infectious Disease Therapeutics Market Share by Country (2017-2028)
Figure 24. Germany Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Infectious Disease Therapeutics Market Share by Region (2017-2028)
Figure 32. China Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Infectious Disease Therapeutics Market Share by Country (2017-2028)
Figure 40. Mexico Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Infectious Disease Therapeutics Market Share by Country (2017-2028)
Figure 44. Turkey Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Infectious Disease Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Novartis AG Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 47. Gilead Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 48. GlaxoSmithKline plc Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 49. Janssen Pharmaceutical Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 50. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 51. BioCryst Pharmaceuticals Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 52. Merck & Co. Inc. Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 53. Boehringer Ingelheim GmbH Revenue Growth Rate in Infectious Disease Therapeutics Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock